Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11981715 Tissue targeted immunotolerance with a CD39 effector

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Joanne L. Viney0

Kevin Lewis Otipoby0

Susmita Borthakur0

Daniel Rios0

Salvatore Alioto0

Lindsay J. Edwards0

Purvi Mande0

Nathan Higginson-Scott0

Date of Patent

May 14, 2024

0

Patent Application Number

171789260

Date Filed

February 18, 2021

0

Patent Citations

US Patent 10308696 IL2 and TNF immunoconjugates

0

US Patent 10350266 Method of treating cancer with a multiple integrin binding Fc fusion protein

0

US Patent 10350304 Nucleic acid products and methods of administration thereof

0

US Patent 10358477 IL-15Ralpha sushi domain—IL-15 fusion proteins

0

US Patent 10363273 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

0

US Patent 10363321 Nucleic acid products and methods of administration thereof

0

US Patent 10376564 Interleukin-2 for treating food allergy

0

US Patent 10428145 PD-1 binding proteins and methods of use thereof

0

...

Patent Primary Examiner

0

Patent abstract

Methods and compounds for conferring site-specific or local immune privilege, such as to the skin.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11981715 Tissue targeted immunotolerance with a CD39 effector

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool